Scholarly Index
Kelong Han
GlaxoSmithKline (United States); 1,449 total citations; 56 total publications; best world rank #103
GlaxoSmithKline (United States)
1,449Total citations
56Total publications
21H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HIV/AIDS drug development and treatment | 2021-2025 | 254 | US 84 | 92.71 |
| Intramuscular injections and effects | 2021-2025 | 103 | US 20 | 70.21 |